Remote Jobs at Lycia Therapeutics
Lycia Therapeutics
11 - 50 employees
🧬 Biotechnology
🏥 Healthcare
💊 Pharmaceuticals
💰 $70M Series B on 2021-09
Biotechnology • Healthcare • Pharmaceuticals
Lycia Therapeutics is a Series B biotech company building upon the novel platform developed by academic founder Professor Carolyn Bertozzi at Stanford University. It specializes in creating LYTAC (lysosomal targeting chimera) protein degraders, which utilize the cell’s lysosomal trafficking and degradation pathway to target both soluble and membrane-bound extracellular proteins. The LYTAC platform aims to tackle challenging membrane proteins, clear pathogenic immune complexes in circulation, and deplete antibodies to specific antigens, potentially providing innovative therapeutics for cancer and autoimmune diseases.
📡 We watch Lycia Therapeutics's careers page
Every 2 hours
how often we check
1
roles posted in the last 30 days
1
roles closed in the last year
Is on LinkedIn?
